์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ
Merck
๋ชจ๋“  ์‚ฌ์ง„(1)

์ฃผ์š” ๋ฌธ์„œ

CBR00275

Sigma-Aldrich

5-Amino-5-oxopentanoic acid

AldrichCPR

๋กœ๊ทธ์ธ์กฐ์ง ๋ฐ ๊ณ„์•ฝ ๊ฐ€๊ฒฉ ๋ณด๊ธฐ


About This Item

์‹คํ—˜์‹(Hill ํ‘œ๊ธฐ๋ฒ•):
C5H9NO3
CAS Number:
Molecular Weight:
131.13
MDL number:
UNSPSC ์ฝ”๋“œ:
12352106
PubChem Substance ID:

ํ˜•ํƒœ

solid

SMILES string

O=C(CCCC(O)=O)N

InChI

1S/C5H9NO3/c6-4(7)2-1-3-5(8)9/h1-3H2,(H2,6,7)(H,8,9)

InChI key

GTFMAONWNTUZEW-UHFFFAOYSA-N

๊ธฐํƒ€ ์ •๋ณด

Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product. Buyer assumes responsibility to confirm product identity and/or purity. All sales are final.

NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICHโ€ฒS STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.

๋ฒ•์  ์ •๋ณด

Product of ChemBridge Corp.

ํ”ฝํ† ๊ทธ๋žจ

Exclamation mark

์‹ ํ˜ธ์–ด

Warning

์œ ํ•ด ๋ฐ ์œ„ํ—˜ ์„ฑ๋ช…์„œ

์˜ˆ๋ฐฉ์กฐ์น˜ ์„ฑ๋ช…์„œ

Hazard Classifications

Eye Irrit. 2

Storage Class Code

11 - Combustible Solids

Flash Point (ยฐF)

Not applicable

Flash Point (ยฐC)

Not applicable


๊ฐ€์žฅ ์ตœ์‹  ๋ฒ„์ „ ์ค‘ ํ•˜๋‚˜๋ฅผ ์„ ํƒํ•˜์„ธ์š”:

์‹œํ—˜ ์„ฑ์ ์„œ(COA)

Lot/Batch Number

์ฃ„์†กํ•ฉ๋‹ˆ๋‹ค. ์ง€๊ธˆ์€ ์ด ์ œํ’ˆ์— ๋Œ€ํ•œ COA์ด(๊ฐ€) ์˜จ๋ผ์ธ์—์„œ ์ œ๊ณต๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

๋„์›€์ด ํ•„์š”ํ•˜์‹œ๋ฉด ์—ฐ๋ฝํ•˜์„ธ์š”. ๊ณ ๊ฐ ์ง€์› ๋ถ€์„œ

์ด ์ œํ’ˆ์„ ์ด๋ฏธ ๊ฐ€์ง€๊ณ  ๊ณ„์‹ญ๋‹ˆ๊นŒ?

๋ฌธ์„œ ๋ผ์ด๋ธŒ๋Ÿฌ๋ฆฌ์—์„œ ์ตœ๊ทผ์— ๊ตฌ๋งคํ•œ ์ œํ’ˆ์— ๋Œ€ํ•œ ๋ฌธ์„œ๋ฅผ ์ฐพ์•„๋ณด์„ธ์š”.

๋ฌธ์„œ ๋ผ์ด๋ธŒ๋Ÿฌ๋ฆฌ ๋ฐฉ๋ฌธ

Cholecystokinin receptor antagonists.
K A Zucker et al.
The Journal of surgical research, 45(5), 496-504 (1988-11-01)
T Takรกcs et al.
International journal of pancreatology : official journal of the International Association of Pancreatology, 10(1), 1-8 (1991-09-01)
In this article, the effects of different classes of cholecystokinin (CCK) receptor antagonists in CCK-related physiological processes of the pancreas have been discussed. Both glutaramic acid derivatives and natural (benzodiazepine) analogs are potent, competitive antagonists of peripheral CCK receptors. These
D J Goon et al.
Bioconjugate chemistry, 5(5), 418-422 (1994-09-01)
By use of a glutaramyl-beta-alanyl spacer group, a hapten for the polychlorinated biphenyl, 2,2',4,4',5,5'-hexachlorobiphenyl (1), viz., 2-amino-2',4,4',5,5'-pentachlorobiphenyl (2), was successfully conjugated to carrier proteins to provide immunogens with high hapten/protein molar substitution ratios (MSR's). The procedure allows for the incorporation

์ž์‚ฌ์˜ ๊ณผํ•™์žํŒ€์€ ์ƒ๋ช… ๊ณผํ•™, ์žฌ๋ฃŒ ๊ณผํ•™, ํ™”ํ•™ ํ•ฉ์„ฑ, ํฌ๋กœ๋งˆํ† ๊ทธ๋ž˜ํ”ผ, ๋ถ„์„ ๋ฐ ๊ธฐํƒ€ ๋งŽ์€ ์˜์—ญ์„ ํฌํ•จํ•œ ๋ชจ๋“  ๊ณผํ•™ ๋ถ„์•ผ์— ๊ฒฝํ—˜์ด ์žˆ์Šต๋‹ˆ๋‹ค..

๊ณ ๊ฐ์ง€์›ํŒ€์œผ๋กœ ์—ฐ๋ฝ๋ฐ”๋ž๋‹ˆ๋‹ค.